XML 21 R8.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Operating activities:      
Net income $ 807,799,000 $ 793,560,000 $ 266,745,000
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 191,946,000 212,405,000 218,984,000
Stock-based compensation expense 90,566,000 98,570,000 62,540,000
Deferred taxes (30,702,000) (41,567,000) (53,190,000)
Loss on impairment of lease related assets, net 53,970,000 49,537,000 0
Loss on extinguishment of debt 0 0 44,814,000
Reduction in the carrying amount of operating lease right-of-use assets 70,086,000 75,125,000 81,851,000
Amortization and write-off of deferred financing fees 4,574,000 4,162,000 8,424,000
Amortization of deferred swap losses from de-designation 0 0 10,320,000
Gain on de-designated swaps (52,308,000) (20,204,000) (2,157,000)
Changes in assets and liabilities, net of acquisitions and divestitures:      
Fees receivable, net (240,696,000) (145,346,000) 99,409,000
Deferred commissions 5,574,000 (124,874,000) 8,656,000
Prepaid expenses and other current assets (3,039,000) (15,913,000) 37,895,000
Other assets 8,440,000 (18,287,000) (8,950,000)
Deferred revenues 297,124,000 324,059,000 15,998,000
Accounts payable and accrued and other liabilities (101,912,000) 121,243,000 111,939,000
Cash provided by operating activities 1,101,422,000 1,312,470,000 903,278,000
Investing activities:      
Additions to property, equipment and leasehold improvements (108,050,000) (59,834,000) (83,888,000)
Acquisitions - cash paid (net of cash acquired) (9,508,000) (22,939,000) 0
Other 0 2,306,000 0
Cash used in investing activities (117,558,000) (80,467,000) (83,888,000)
Financing activities:      
Proceeds from employee stock purchase plan 22,231,000 18,173,000 18,085,000
Proceeds from borrowings 0 600,000,000 2,000,000,000
Early redemption premium payment 0 0 (30,752,000)
Payments for deferred financing fees 0 (7,320,000) (25,786,000)
Proceeds from revolving credit facility 0 0 332,000,000
Payments on revolving credit facility 0 (5,000,000) (475,000,000)
Payments on borrowings (5,931,000) (107,915,000) (2,058,469,000)
Purchases of treasury stock (1,043,742,000) (1,655,547,000) (176,302,000)
Cash used in financing activities (1,027,442,000) (1,157,609,000) (416,224,000)
Net (decrease) increase in cash and cash equivalents and restricted cash (43,578,000) 74,394,000 403,166,000
Effects of exchange rates on cash and cash equivalents and restricted cash (18,425,000) (26,375,000) 28,581,000
Cash and cash equivalents and restricted cash, beginning of year 760,602,000 712,583,000 280,836,000
Cash and cash equivalents and restricted cash, end of year 698,599,000 760,602,000 712,583,000
Cash paid during the year for:      
Interest 112,825,000 101,885,000 112,249,000
Income taxes, net of refunds received $ 174,802,000 $ 253,379,000 $ 33,921,000